Remission after potassium iodide therapy in patients with graves' hyperthyroidism exhibiting thionamide-associated side effects

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages 3995-4002

  Okamura, Ken ^a   Sato, Kaori ^a   Fujikawa, Megumi ^a   Bandai, Sachiko ^a   Ikenoue, Hiroshi ^a   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; IODINE; LEVOTHYROXINE; POTASSIUM IODIDE; THIONAMIDE; ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; EYE DISEASE; FEMALE; GOITER; GRAVES DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPOTHYROIDISM; INTOXICATION; LEUKOPENIA; LIVER DYSFUNCTION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RASH; REMISSION; SIALOADENITIS; THYROID WEIGHT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; ADOLESCENT; DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; RETREATMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; POTASSIUM IODIDE; PROPYLTHIOURACIL; REMISSION INDUCTION; RETREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84910018444     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4466     Document Type: Article

References (39)

1. Astwood EB. Thyroid and antithyroid drugs. In: Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 3rd ed. New York: The Macmillan Company; 1965: 1466-1503.
2. Thompson WO, Thompson PK, Brailey AG, Cohen AC. Prolonged treatment of exophthalmic goiter by iodine alone. Arch Intern Med. 1930;45: 481-502.
3. Volpe R, Johnston MW. The effect of small doses of stable iodine in patients with hyperthyroidism. Ann Intern Med. 1962;56: 577-589.
4. Plummer HS. Results of administering iodine to patients having exophthalmic goiter. JAMA. 1923;80: 1955.
5. Plummer HS, Boothby WM. The value of iodin in exophthalmic goiter. J Iowa Med Soc. 1924;14: 66-73.
6. Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid. 1998;8: 83-100.
7. Vagenakis AG, Wang CA, Burger A, Maloof F, Braverman LE, SH. Iodide-induced thyrotoxicosis in Boston. N Engl J Med. 1972;287: 523-527.
8. Emerson CH, Anderson AJ, Howard WJ, Utiger RD. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab. 1975;40: 33-36.
9. Philippou G, Koutras DA, Piperingos G, Souvatzoglou A, Moulo poulos SD. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf). 1992;36: 573-578.
10. Roti E, Robuschi G, Manfredi A, et al. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. Clin Endocrinol (Oxf). 1985;22: 489-496.
11. Tan TT, Morat P, Ng ML, Khalid BA. Effects of Lugol's solution on thyroid function in normals and patients with untreated thyrotoxicosis. Clin Endocrinol (Oxf). 1989;30: 645-649.
12. Feek CM, Sawers JS, Irvine WJ, Beckett GJ, Ratcliffe WA, Toft AD. Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. N Engl J Med. 1980;302: 883-885.
13. Braverman LE, Woeber KA, Ingbar SH. Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter. N Engl J Med. 1969;281: 816-821.
14. Okamura K, Ikenoue H, Shiroozu A, Sato K, Yoshinari M, Fujishima M. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1987;65: 719-723.
15. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352: 905-917.
16. Ikenoue H, Okamura K, Sato K, et al. Prediction of relapse in drugtreated Graves' disease using thyroid stimulation indices. Acta Endocrinol (Copenh). 1991;125: 643-650.
17. Okamura K, Sato K, Ikenoue H, et al. Reevaluation of the thyroidal radioactive iodine uptake test, with special reference to reversible primary hypothyroidism with elevated thyroid radioiodine uptake. J Clin Endocrinol Metab. 1988;67: 720-726.
18. Sato K, Okamura K, Yoshinari M, et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh). 1992;126: 253-259.
19. Yoshinaga J, Morita M. Determination of iodine in biological fluids by ICP-MS. Biomed Res Trace Elements. 1991;2: 143-144.
20. Wilson R, McKillop JH, Thomson JA. The effect of pre-operative potassium iodide therapy on antibody production. Acta Endocrinol (Copenh). 1990;123: 531-534.
21. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 1948;174: 555-564.
22. Okamura K, Sato K, Fujishima M. Reversible or irreversible thyroid dysfunction in Hashimoto thyroiditis. In: Nagataki S, Mori T, Torizuka K, eds. 80 Years of Hashimoto Disease. Amsterdam, The Netherlands: Elsevier Science Publishers; 1993: 149-154.
23. Pisarev MA, Gärtner R. Autoregulatory action of iodine. In: Braverman LE, Utiger RD, eds. Werner, Ingbar's The Thyroid. A Fundamental and Clinical Text. 8th ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2000: 85-90.
24. Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff- Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology. 1999;140: 3404-3410.
25. Harden RM, Koutras DA, Alexander WD, Wayne EJ. Quantitative studies of iodine metabolism in iodide-treated thyrotoxicosis. Clin Sci. 1964;27: 399-405.
26. Stewart RD, Murray IP. Effect of small doses of carrier iodide upon the organic binding of radioactive iodine by the human thyroid gland. J Clin Endocrinol Metab. 1967;27: 500-508.
27. Nagataki S. Effect of excess quantities of iodide. In: Greep RO, Astwood EB, eds. Handbook of Physiology. Volume III. Thyroid. Washington, DC: American Physiological Society; 1974: 329-344.
28. Taurog AM. Thyroid hormone synthesis: thyroid iodine metabolism. In: Braverman LE, Utiger RD, eds. Werner, Ingbar's the Thyroid. AFundamental and Clinical Text. 8th ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2000: 61-85.
29. Many MC, Mestdagh C, van den Hove MF, Denef JF. In vitro study of acute toxic effects of high iodide doses in human thyroid follicles. Endocrinology. 1992;131: 621-630.
30. Braverman LE, Ingbar SH, Vagenakis AG, Adams L, Maloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab. 1971;32: 515-521.
31. Okamura K, Inoue K, Omae T. A case of Hashimoto's thyroiditis with thyroid immunological abnormality manifested after habitual ingestion of seaweed. Acta Endocrinol (Copenh). 1978;88: 703-712.
32. Sato K, Okamura K, Hirata T, et al. Immunological and chemical types of reversible hypothyroidism; clinical characteristics and longterm prognosis. Clin Endocrinol (Oxf). 1996;45: 519-528.
33. Weetman AP, McGregor AM, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol (Oxf). 1984;21: 163-172.
34. Wenzel KW, Lente JR. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. J Clin Endocrinol Metab. 1984;58: 62-69.
35. Inoue K, Taurog A. Acute and chronic effects of iodide on thyroid radioiodine metabolism in iodine-deficient rats. Endocrinology 1968;83: 279-290.
36. Hays MT. Estimation of total body iodine content in normal young men. Thyroid. 2001;11: 671-675.
37. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab. 1987;64: 1241-1245.
38. Ingbar SH. Autoregulation of the thyroid. Response to iodide excess and depletion. Mayo Clin Proc. 1972;47: 814-823.
39. Rienhoff WF Jr. Involutional or regressive changes in the thyroid gland in cases of exophthalmic goiter and their relation to the origin of certain of the so-called adenomas. Arch Surg. 1926;13: 391-425.